ArticleChemMedChem2026
Development of Morin-Loaded Hydrogel as a Bioactive Platform for Potential Topical Applications: Experimental and Theoretical Analysis of Drug-Polymer Interactions.
Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Topical delivery systems represent a promising strategy to reduce adverse effects associated with conventional therapies devoted to the treatment of skin disorders. This study deals with the fabrication of a biopolymeric platform for topical delivery of morin (M), a bioactive flavonoid with antioxidant and anticancer properties. Hydrogels based on gelatin (G), chitosan (Ch), and arabic gum (AG) were synthesized by freeze-thaw method. M was loaded to impart the therapeutic action. Characterization of hydrogels demonstrated that Ch incorporation improved mechanical and thermal properties, swelling, and water stability. Two loading methods were explored to incorporate M: surface adsorption and drug encapsulation during gel formation. The reached efficiencies were 42% and 100% for adsorption and encapsulation, respectively. Antioxidant activity, evaluated by scavenging DPPH radicals (%), was also enhanced by M loading reaching 45% versus 22% when the raw hydrogel was assayed. In vitro cytotoxicity studies confirmed the biosafety of formulations. Drug release experiments showed that 65% of M was released from hydrogel after 120 min in a skin-simulating medium. Molecular simulations were performed to justify the M retention. The achieved findings highlight the critical role of molecular-level interactions in governing M release, providing guidelines for the development of hydrogel-based topical delivery systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.